PN6047 Demonstrates Broad Preclinical Efficacy in Headache Models as a Novel Delta-Opioid Receptor Agonist
Yaseen Awad-Igbaria, Yanping Zhang, Mattin Aframian, Guido C. Faas, Andrew Charles, Serapio M. Baca, Emily M. Jutkiewicz, Bengt von Mentzer, John R. Traynor, David Kendall, Amynah A. A. Pradhan
This paper evaluates the efficacy of PN6047, a novel DOR agonist, in preclinical headache models and finds it effectively reduces pain and prevents medication overuse headache.
The Journal of Headache and Pain · Aug 6, 2026Peer-reviewedNeuroscience